2003
DOI: 10.1080/713831596
|View full text |Cite
|
Sign up to set email alerts
|

An Unusual Syncytia-Inducing Human Immunodeficiency Virus Type 1 Primary Isolate from the Central Nervous System that is Restricted to CXCR4, Replicates Efficiently in Macrophages, and Induces Neuronal Apoptosis

Abstract: Macrophage/microglia cells are the principal targets for human immunodeficiency virus type 1 (HIV-1) in the central nervous system (CNS). Prototype HIV-1 isolates from the CNS are macrophage (M)-tropic, non-syncytia-inducing (NSI), and use CCR5 for entry (R5 strains), but whether syncytia-inducing (SI) CXCR4-using X4 strains might play a role in macrophage/microglia infection and neuronal injury is unknown. To explore the range of features among HIV-1 primary isolates from the CNS, the authors analyzed an HIV-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
20
0

Year Published

2004
2004
2018
2018

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 15 publications
(21 citation statements)
references
References 35 publications
1
20
0
Order By: Relevance
“…Analysis of the phenotypes of envelopes derived from brain tissue has been limited mainly to viruses isolated into bloodderived lymphocytes (15,16,42,51) or envelope fragments cloned into chimeric viruses (3). A recent report by Ohagen et al (28) described envelope genes that were amplified by PCR from brain tissue without culture.…”
mentioning
confidence: 99%
“…Analysis of the phenotypes of envelopes derived from brain tissue has been limited mainly to viruses isolated into bloodderived lymphocytes (15,16,42,51) or envelope fragments cloned into chimeric viruses (3). A recent report by Ohagen et al (28) described envelope genes that were amplified by PCR from brain tissue without culture.…”
mentioning
confidence: 99%
“…Though typically the syncytiuminducing phenotype has been assigned to HIV strains that efficiently induce syncytia in transformed T cells in vitro (i.e., CXCR4-using strains), many R5 HIV-1 strains promote syncytia formation in primary macrophages albeit with variable efficacy, and their different ability in forming syncytia has been suggested to associate with their neuropathogenic potential (Gorry et al, 2002). On the other hand, although brain-derived viruses predominantly use CCR5, viruses that exclusively use CXCR4 for infection of microglia/macrophages have been identified (Gorry et al, 2005) and rarely reported in the CSF (Yi et al, 2003). Thus, both CXCR4 and CCR5-using viruses can potentially induce macrophage syncytia and contribute to HAD, though adaptive viral evolution appears to favor M-tropism of R5 HIV-1 strains (Gorry et al, 2005).…”
Section: Discussionmentioning
confidence: 99%
“…Brain-derived viruses generally use CCR5 for entry (Gonzalez-Scarano and Martin-Garcia, 2005), but viruses exploiting CXCR4 as co-receptor (or dual tropic viruses) are also found in the CNS and able to infect macrophages (Yi et al, 2003). These viruses are highly neurotoxic in vitro (Gabuzda and Wang, 2000) and generally predominate in the late stages of the disease.…”
Section: Introductionmentioning
confidence: 99%
“…HIV-E is usually associated with infection with viruses that use the CCR5 coreceptor, although it has been demonstrated recently that viruses that use CXCR4 can also cause the disease. 41 SHIV-E has been clearly associated with viruses that use the CXCR4 co-receptor. 21,42,43 The common factor shared by these viruses was their tropism for macrophages.…”
Section: Discussionmentioning
confidence: 99%